Skip to main content
Premium Trial:

Request an Annual Quote

Mayo Clinic to Use Siemens' Molecular Dx Tools

NEW YORK (GenomeWeb News) – Siemens Healthcare Diagnostics will provide the Mayo Clinic with two of its molecular testing products for use in screening for major diseases, Siemens said today.

Under the five-year agreement, the Mayo Clinic will use Siemens’ Versant and Trugene products to assess human immunodeficiency virus, hepatitis B and hepatitis C viral load, genotyping, and drug resistance.

Siemens also said it will provide planned upgrades to molecular testing systems and software over the course of the agreement as new advances in the technologies are made.

Financial terms of the agreement were not disclosed.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.